Lazard Capital Starts Nektar Therapeutics (NKTR) at Buy
Tweet Send to a FriendGet Alerts NKTR Hot Sheet
Price: $9.31 --0%
Rating Summary:
3 Buy, 1 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 3 | New: 4
Rating Summary:
3 Buy, 1 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 3 | New: 4
Trade NKTR Now!
Lazard Capital initiates coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy. PT $15.00.
For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.
Shares of Nektar Therapeutics closed at $8.74 yesterday, with a 52 week range of $5.65-$10.98.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.
Shares of Nektar Therapeutics closed at $8.74 yesterday, with a 52 week range of $5.65-$10.98.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Topeka Capital Starts InvenSense (INVN) at Buy
- Maxim Group Starts First Republic Bank (FRC) at Buy
- Topeka Capital Starts Cavium Networks (CAVM) at Hold
Create E-mail Alert Related Categories
New CoverageRelated Entities
Lazard
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
